Evidence map›Paper›PMID 15138768›Full record

ArticleChromosoma2004

TopBP1 localises to centrosomes in mitosis and to chromosome cores in meiosis.

Kaarina Reini, Lahja Uitto, David Perera, Peter B Moens, Raimundo Freire, Juhani E Syväoja

Abstract read
PubMed Publisher
In one paragraph

Article in Chromosoma, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. DNA damage response protein TOPBP1 regulates X chromosome silencing in the mammalian germ line.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. The DNA-damage effector checkpoint kinase 1 is essential for chromosome segregation and cytokinesis.Proceedings of the National Academy of Sciences of the United States of America · 2009
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Kaarina ReiniBiocenter Oulu and Department of Biochemistry, P.O. Box 3000, 90014, University of Oulu, Finland.
Lahja Uitto
David Perera
Peter B Moens
Raimundo Freire
Juhani E Syväoja
Hospital Universitario de Canarias · ESUniversity of Oulu · FIJoensuu Science Park · FIYork University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Topoisomerase IIbeta binding protein 1 (TopBP1), previously shown to localise to sites of DNA damage and to stalled replication forks, has been implicated in DNA replication and in DNA damage response. In this work we showed that TopBP1 was localised in structures other than stalled replication forks. In late mitosis TopBP1 localises to centrosomes in a manner similar to other DNA damage response proteins such as BRCA1 and p53. Spindle checkpoint activation does not affect this centrosomal localisation. Moreover, in the testis, we detected high levels of TopBP1 associated with meiotic prophase chromosome cores and the X-Y pair. Together, these data suggest a direct role of TopBP1 during both mitosis and meiotic prophase I.

Indexed as

Meiotic Prophase IMitosisAnaphaseBRCA1 ProteinCarrier ProteinsCell Line, TumorCentrosomeChromosomesDNA-Binding ProteinsEnzyme ActivationFemaleHeLa CellsHumansMaleMetaphaseNocodazoleBRCA1 ProteinCarrier ProteinsDNA-Binding ProteinsmonastrolNocodazoleNuclear ProteinsPyrimidinesThionesTOPBP1 protein, human

Identifiers

PMID15138768
OpenAlexW2088499516

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.